A detailed history of Bellevue Group Ag transactions in Moderna, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 1,600,836 shares of MRNA stock, worth $63.1 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
1,600,836
Previous 1,563,735 2.37%
Holding current value
$63.1 Million
Previous $186 Million 42.39%
% of portfolio
1.8%
Previous 3.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $2.36 Million - $4.64 Million
37,101 Added 2.37%
1,600,836 $107 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $14.9 Million - $24.6 Million
-147,354 Reduced 8.61%
1,563,735 $186 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $16.8 Million - $22.8 Million
-197,331 Reduced 10.34%
1,711,089 $182 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $28.7 Million - $43.1 Million
413,095 Added 27.63%
1,908,420 $190 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $2.87 Million - $3.76 Million
-29,734 Reduced 1.95%
1,495,325 $154 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $3.16 Million - $4.28 Million
-26,647 Reduced 1.72%
1,525,059 $185 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $4.15 Million - $6.03 Million
-30,622 Reduced 1.94%
1,551,706 $238 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $2.67 Million - $4.73 Million
22,527 Added 1.44%
1,582,328 $284 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $2.07 Million - $3.41 Million
-17,550 Reduced 1.11%
1,559,801 $184 Million
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $7.26 Million - $10.9 Million
-61,998 Reduced 3.78%
1,577,351 $225 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $8.84 Million - $16.4 Million
-69,900 Reduced 4.09%
1,639,349 $282 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $4.09 Million - $6.67 Million
-18,100 Reduced 1.05%
1,709,249 $434 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $181 Million - $395 Million
-814,951 Reduced 32.06%
1,727,349 $665 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $34.8 Million - $62.9 Million
-267,650 Reduced 9.53%
2,542,300 $597 Million
Q1 2021

May 12, 2021

SELL
$109.18 - $185.98 $15 Million - $25.5 Million
-136,963 Reduced 4.65%
2,809,950 $368 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $26 Million - $67.1 Million
-395,037 Reduced 11.82%
2,946,913 $308 Million
Q3 2020

Nov 16, 2020

SELL
$54.34 - $94.85 $163,020 - $284,550
-3,000 Reduced 0.09%
3,341,950 $236 Million
Q2 2020

Aug 13, 2020

SELL
$29.67 - $80.0 $18 Million - $48.4 Million
-605,231 Reduced 15.32%
3,344,950 $215 Million
Q1 2020

May 14, 2020

SELL
$17.78 - $31.58 $17.5 Million - $31.1 Million
-984,900 Reduced 19.96%
3,950,181 $118 Million
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $1.27 Million - $1.94 Million
91,000 Added 1.88%
4,935,081 $96.5 Million
Q3 2019

Nov 14, 2019

BUY
$12.26 - $18.07 $1.47 Million - $2.17 Million
119,835 Added 2.54%
4,844,081 $77.1 Million
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $64.7 Million - $134 Million
4,724,246 New
4,724,246 $69.2 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.